Kanser Biyolojisi ve Farmakolojisi (YL) (Tezli)
Ders İçerikleri
1. Semester
| Course Code | Course Name | (T+A+L) | ECTS | Compulsory/Elective |
| KBY5113 | Cancer Biology and Genetics | 3+0+ | 5 | Compulsory |
| Molecular and genetic mechanisms in cancer. | ||||
| Course Code | Course Name | (T+A+L) | ECTS | Compulsory/Elective |
| LEE5500 | Scientific Research Methods and Ethics | 3+0+0 | 9 | Compulsory |
| It includes topics such as science, scientific research, types of scientific research, stages of scientific research, scientific research and publication ethics. | ||||
2. Semester
| Course Code | Course Name | (T+A+L) | ECTS | Compulsory/Elective |
| KBY5104 | Cancer Pharmacology | 3+0+ | 8 | Compulsory |
| General pharmacology concepts; absorption, distribution, excretion and detoxification mechanisms; features of the autonomic nervous system, neurotransmitters, drugs used in some diseases and their mechanisms of action; Drugs used in cancer treatment, their mechanism of action and adverse effects | ||||
| Course Code | Course Name | (T+A+L) | ECTS | Compulsory/Elective |
| KBY5171 | Seminar | 0+0+0 | 6 | Compulsory |
| Making a presentation on a thesis topic | ||||
3. Semester
| Course Code | Course Name | (T+A+L) | ECTS | Compulsory/Elective |
| KBY5191 | Thesis Study 1 | 0+0+0 | 30 | Compulsory |
| Thesis | ||||
4. Semester
| Course Code | Course Name | (T+A+L) | ECTS | Compulsory/Elective |
| KBY5192 | Thesis Study 2 | 0+0+0 | 30 | Compulsory |
| Thesis | ||||
Department/Programme Elective Courses
| Course Code | Course Name | (T+A+L) | ECTS |
| KBY5011 | Cancer Bioinformatics | 3+0+0 | 8 |
| The content of this course is the effective use of bioinformatics tools during cancer research and targeted drug design approaches. Another important content of the course is to convey basic information about the effective use of existing mathematical models during the experimental design phase and the interpretation of the results. The elements necessary for drug design will be emphasised with the multiple perspectives that will be gained to the students. | |||
| Course Code | Course Name | (T+A+L) | ECTS |
| KBY5012 | Tumor Heterogeneity and Drug Resistance | 3+0+0 | 8 |
| Molecular and genetic mechanisms of tumoral heterogeneity in cancer and cancer drug resistance that develops in parallel with it. | |||
| Course Code | Course Name | (T+A+L) | ECTS |
| KBY5013 | Current Advancements in Cancer Research | 3+0+0 | 8 |
| 1. novel drugs 2. microbiota 3. spheroids 4. organoids 5. in ovo method 6. new hallmarks 7. new cell death modalities 8. nobel-related developments | |||
| Course Code | Course Name | (T+A+L) | ECTS |
| KBY5014 | Cancer Cell Metabolism | 3+0+ | 8 |
| Changes in cellular metabolism in cancer | |||
| Course Code | Course Name | (T+A+L) | ECTS |
| KBY5015 | Anticancer Drug Discovery | 3+0+0 | 8 |
| introduction to cancer biology anticancer drug types mechanisms cell death types mechanisms cytotoxicity tests uses advantages and disadvantages | |||